Resistance of Vaccinia Virus to Inactivation by Solvent/Detergent Treatment of Blood Products
- 1 March 2000
- journal article
- Published by Elsevier in Biologicals
- Vol. 28 (1) , 29-32
- https://doi.org/10.1006/biol.1999.0236
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Virus Safety of Plasma ProductsReviews in Medical Virology, 1996
- Virological safety of the purified factor IX concentrate, ReplenineHaemophilia, 1995
- Development and characterization of the high‐purity factor IX, ReplenineHaemophilia, 1995
- Safety aspects in the manufacturing of plasma-derived coagulation factor concentratesBiologicals, 1992
- Ultrapure plasma factor VIII produced by anti-FVIIIc immunoaffinity chromatography and solvent/detergent viral inactivation. Characterization of the Method M process and Hemofil M antihemophilic factor (human)Annals of Hematology, 1991
- STERILISATION OF HEPATITIS AND HTLV-III VIRUSES BY EXPOSURE TO TRI(n-BUTYL)PHOSPHATE AND SODIUM CHOLATEThe Lancet, 1986
- Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinationsTransfusion, 1985
- Inactivation of Hepatitis B and Hutchinson Strain Non‐A, Non‐B Hepatitis Viruses by Exposure to Tween 80 and Ether1Vox Sanguinis, 1984